|
FAM49B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.192000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.209600E-01 |
| Normal-vs-Stage2 |
4.197800E-02 |
| Normal-vs-Stage3 |
4.788000E-02 |
| Normal-vs-Stage4 |
1.538050E-02 |
| Stage1-vs-Stage2 |
1.331250E-01 |
| Stage1-vs-Stage3 |
1.846970E-01 |
| Stage1-vs-Stage4 |
5.627600E-02 |
| Stage2-vs-Stage3 |
5.819200E-01 |
| Stage2-vs-Stage4 |
9.468800E-01 |
| Stage3-vs-Stage4 |
4.794000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.104300E-02 |
| Normal-vs-AfricanAmerican |
9.749200E-01 |
| Normal-vs-Asian |
3.977700E-02 |
| Caucasian-vs-AfricanAmerican |
6.279700E-02 |
| Caucasian-vs-Asian |
2.323000E-01 |
| AfricanAmerican-vs-Asian |
5.277700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.039630E-02 |
| Normal-vs-Female |
2.609000E-01 |
| Male-vs-Female |
5.542400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.586800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.498200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.384300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.511200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.117400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.898800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.910600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.137400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.795400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.381800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.722400E-01 |
| Normal-vs-Grade 2 |
1.733570E-01 |
| Normal-vs-Grade 3 |
4.513600E-02 |
| Normal-vs-Grade 4 |
6.183600E-03 |
| Grade 1-vs-Grade 2 |
2.214800E-01 |
| Grade 1-vs-Grade 3 |
1.054430E-01 |
| Grade 1-vs-Grade 4 |
1.343690E-02 |
| Grade 2-vs-Grade 3 |
5.032200E-01 |
| Grade 2-vs-Grade 4 |
5.079500E-02 |
| Grade 3-vs-Grade 4 |
1.055800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.030200E-01 |
| Normal-vs-ccB subtype |
1.364100E-03 |
| ccA subtype-vs-ccB subtype |
3.039700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.368400E-02 |
| Normal-vs-N1 |
1.710390E-02 |
| N0-vs-N1 |
5.589800E-02 |
|
|
